New Tadalafil Tablets Granted FDA Approval

Article

Glenmark's drug product is a generic equivalent to Eli Lilly’s Cialis Tablets.

Officials with the FDA have approved Glenmark Pharmaceuticals’ Tadalafil Tablets USP, 2.5 mg, 5 mg, 10 mg and 20 mg.1

This drug product is a new generic equivalent to Eli Lilly’s Cialis Tablets, 2.5 mg, 5 mg, 10 mg and 20 mg,1 which is indicated for erectile dysfunction and the treatment of benign prostatic hyperplasia.2

The most common adverse reactions (≥ 2%) for tadalafil are headache, flushing, dyspepsia, nasal congestion, back pain, myalgia, and pain in limb.2

Sales data for the 12 month period ending November 2020, the Cialis Tablets, 2.5 mg, 5 mg, 10 mg and 20 mg market achieved annual sales of approximately $125.5 million.1

REFERENCES

  • Glenmark Pharmaceuticals receives ANDA final approval for Tadalafil Tablets, 2.5 mg, 5 mg, 10 mg and 20 mg; and receives ANDA tentative approvals for Gabapentin Enacarbil Extended-Release Tablets, 300 mg and 600 mg and Apremilast Tablets, 10 mg, 20 mg and 30 mg [news release]. Mumbai, India; December 31, 2020: Glenmark Pharmaceuticals. [email].
  • Cialis [prescribing information]. Indianapolis, IN; Eli Lilly & Company; 2018.

Related Videos
Image credit:  Gorodenkoff | stock.adobe.com
Sun Screen, Photosensitivity, Pharmacy | Image Credit: sosiukin - stock.adobe.com
Catalyst Trial, Diabetes, Hypertension | Image Credit: grinny - stock.adobe.com
Various healthy foods -- Image credit: New Africa | stock.adobe.com
LGBTQIA+ pride -- Image credit: lazyllama | stock.adobe.com
Modern pharmacy building facade with large window showcasing the interior, as seen from the street view, promoting a welcoming atmosphere for customers. Frontal view. Generative AI - Image credit: Karrrtinki | stock.adobe.com
Close up hands of helping hands elderly home care. Mother and daughter. Mental health and elderly care concept - Image credit:  ipopba | stock.adobe.com
Rear view of Audience listening Speakers on the stage in the conference hall or seminar meeting, business and education about investment concept -  Image credit: THANANIT | stock.adobe.com
© 2024 MJH Life Sciences

All rights reserved.